Literature DB >> 1601989

Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro.

J D Smith1, E A Brinton, J L Breslow.   

Abstract

We investigated a common polymorphism in the human apolipoprotein A-I gene promoter at a position 76 bp upstream of the transcriptional start site. 54 human subjects, whose apoAI production rates had been determined by apoAI turnover studies, were genotyped at this polymorphic position by a novel technique using polymerase chain reaction followed by primer extension. 35 subjects were homozygous for a guanosine (G) at this locus and 19 were heterozygous with a guanosine and adenosine (A). The apoAI production rates were significantly lower (by 11%) in the G/A heterozygotes than in the G homozygotes (P = 0.025). In spite of the apparent effect of this apoAI gene promoter polymorphism on the apoAI production rate, there was no effect on HDL cholesterol or apoAI levels. To investigate whether the observed difference in apoAI production rates was related to differential gene expression of the two alleles, promoters containing either allele were linked to the reporter gene chloramphenicol acetyltransferase, and relative promoter efficiencies were determined after transfection into the human HepG2 hepatoma cell line. The A allele expressed only 68% +/- 5% as well as the G allele, a result consistent with the in vivo apoAI production rate data.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601989      PMCID: PMC295877          DOI: 10.1172/JCI115783

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Efficient DNA isolation within a single gel barrier tube.

Authors:  R F Moreno; F R Booth; I H Hung; L L Tilzer
Journal:  Nucleic Acids Res       Date:  1989-10-25       Impact factor: 16.971

2.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

3.  Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements.

Authors:  J D Smith; A Melián; T Leff; J L Breslow
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

5.  Isolation and characterization of the human apolipoprotein A-I gene.

Authors:  S K Karathanasis; V I Zannis; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

6.  Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia.

Authors:  F Pagani; A Sidoli; G A Giudici; L Barenghi; C Vergani; F E Baralle
Journal:  J Lipid Res       Date:  1990-08       Impact factor: 5.922

7.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Promoter elements and factors involved in hepatic transcription of the human ApoA-I gene positive and negative regulators bind to overlapping sites.

Authors:  P Papazafiri; K Ogami; D P Ramji; A Nicosia; P Monaci; C Cladaras; V I Zannis
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

9.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.

Authors:  A Walsh; Y Ito; J L Breslow
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

10.  Human apolipoprotein CIII gene expression is regulated by positive and negative cis-acting elements and tissue-specific protein factors.

Authors:  K Reue; T Leff; J L Breslow
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

View more
  18 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio.

Authors:  Stefan-Martin Herrmann; Ji-Guang Wang; Jan A Staessen; Ercan Kertmen; Klaus Schmidt-Petersen; Walter Zidek; Martin Paul; Eva Brand
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

3.  Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.

Authors:  S Naganawa; H N Ginsberg; R M Glickman; G S Ginsburg
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.

Authors:  M Dammerman; L A Sandkuijl; J L Halaas; W Chung; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

5.  Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Authors:  W W Li; M M Dammerman; J D Smith; S Metzger; J L Breslow; T Leff
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer.

Authors:  Bechr Hamrita; Hela Ben Nasr; Sallouha Gabbouj; Noureddine Bouaouina; Lotfi Chouchane; Karim Chahed
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

7.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

8.  Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management.

Authors:  Sunita Dodani; Rebecca Henkhaus; Jo Wick; James Vacek; Kamal Gupta; Lei Dong; Merlin G Butler
Journal:  Lipids Health Dis       Date:  2011-03-16       Impact factor: 3.876

9.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

10.  Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?

Authors:  C Ma; Y Zhang; X Li; J Zhang; K Chen; Y Liang; Y Chen; Z Liu; Z Zhang
Journal:  Eur J Neurol       Date:  2016-06-04       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.